Soliton IPO

2/20/2019

IPO

$11,000,000

We believe the net proceeds of this Offering, together with our cash and cash equivalents, including the remaining proceeds from our recent private placement of our unsecured promissory notes, will be sufficient to meet our cash, operational and liquidity requirements for at least 12 months if we sell a minimum of 1,500,000 shares and for at least 12 months if we sell all 3,000,000 shares of our common stock in this Offering. Should we raise the maximum, we will commercialize the device at a faster pace and therefore spend at a faster pace. The operating plan that we would enact should we raise the minimum includes a significant reduction in planned staffing, travel, research and development spending, and other overhead to mirror the reduced pace of development.

Publicly-held

Medical Devices & Instruments

1225 North Loop West 725
Houston, TX 77008
USA

Soliton (Nasdaq: SOLY) is developing breakthrough acoustic shockwave technology to address multiple multibillion-dollar market opportunities.